Display options
Cite
Dharmasaroja PA, Muengtaweepongsa S. Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. J Neurosci Rural Pract. 2016;7(1):36-9doi: 10.4103/0976-3147.172149.
Dharmasaroja, P. A., & Muengtaweepongsa, S. (2016). Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. Journal of neurosciences in rural practice, 7(1), 36-9. https://doi.org/10.4103/0976-3147.172149
Dharmasaroja, Pornpatr A, and Muengtaweepongsa, Sombat. "Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis." Journal of neurosciences in rural practice vol. 7,1 (2016): 36-9. doi: https://doi.org/10.4103/0976-3147.172149
Dharmasaroja PA, Muengtaweepongsa S. Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. J Neurosci Rural Pract. 2016 Jan-Mar;7(1):36-9. doi: 10.4103/0976-3147.172149. PMID: 26933341; PMCID: PMC4750336.
Copy Download .nbib Format: NLM
Share it on

J Neurosci Rural Pract. 2016 Jan-Mar;7(1):36-9. doi: 10.4103/0976-3147.172149.

Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis.

Journal of neurosciences in rural practice

Pornpatr A Dharmasaroja, Sombat Muengtaweepongsa

Affiliations

  1. Department of Internal Medicine, Stroke and Neurodegenerative Diseases Research Unit, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.
  2. Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand.

PMID: 26933341 PMCID: PMC4750336 DOI: 10.4103/0976-3147.172149

Abstract

BACKGROUND: Many thrombolytic studies showed that severe stroke was associated with death and having symptomatic intracerebral hemorrhage and inversely related to a favorable outcome.

AIMS: The purpose of this study is to compare the outcomes of patients with acute large middle cerebral artery (MCA) infarction with and without intravenous recombinant-tissue-plasminogen activator (rtPA) treatment.

METHODS: Patients with acute, large MCA infarction (National Institute of Health Stroke Scale [NIHSS] >15) who were treated during 2011-2014 were studied. The demographic data and the outcomes were compared between patients with and without intravenous rtPA treatment.

RESULTS: Two hundred and forty patients were included. Mean NIHSS score was 20. One hundred and twenty patients were treated with intravenous rtPA treatment. The patients with rtPA treatment had higher rates of favorable outcomes (39% vs. 17%, P < 0.001) and lower mortality rate (16% vs. 51%, P < 0.001). There was no significant difference in the occurrence of symptomatic intracerebral hemorrhage (6% vs. 4%, P = 0.715).

CONCLUSIONS: The study showed the benefit and safety of intravenous rtPA treatment in patients with acute large MCA infarct.

Keywords: Asia; middle cerebral artery; severe stroke; thrombolysis

References

  1. N Engl J Med. 2015 Mar 12;372(11):1009-18 - PubMed
  2. Lancet. 1998 Oct 17;352(9136):1245-51 - PubMed
  3. Lancet. 2012 Jun 23;379(9834):2352-63 - PubMed
  4. N Engl J Med. 2015 Jan 1;372(1):11-20 - PubMed
  5. J Neurol Sci. 2011 Jan 15;300(1-2):74-7 - PubMed
  6. N Engl J Med. 2015 Mar 12;372(11):1019-30 - PubMed
  7. Arch Neurol. 1996 Apr;53(4):309-15 - PubMed
  8. Lancet. 2012 Jun 23;379(9834):2320-1 - PubMed
  9. Stroke. 2008 Dec;39(12):3316-22 - PubMed
  10. Intensive Care Med. 1998 Jun;24(6):620-3 - PubMed
  11. Neurology. 2001 Aug 14;57(3):474-80 - PubMed
  12. Stroke. 2007 Mar;38(3):967-73 - PubMed
  13. Int Angiol. 2001 Sep;20(3):208-13 - PubMed
  14. Stroke. 2013 Mar;44(3):870-947 - PubMed
  15. J Clin Neurosci. 2012 Jun;19(6):799-803 - PubMed
  16. Stroke. 2005 Oct;36(10):2121-5 - PubMed

Publication Types